Digital Chemotherapy Diary
Structured daily schedule with automated pre-medication alerts, hydration prompts, and oral oncolytic adherence trackers.
Explore Patient Diary →OncoCare is India's dedicated oncology platform and cancer care EMR connecting medical, surgical, and radiation oncologists with cancer patients. Featuring protocol-driven chemotherapy ordering, automated BSA dosing, real-time CTCAE symptom triage, and multidisciplinary virtual Tumor Boards on oncocare.tech.
Book accredited doorstep diagnostic lab tests, track chemo cycle roadmaps, report symptom toxicities & consult oncologists.
Explore evidence-based chemotherapy regimens, automatic BSA/AUC dosing calculation, CTCAE toxicity triage & Tumor Board review.
Patients receive structured chemotherapy roadmaps, log daily PROMs (Patient-Reported Outcome Measures), and receive immediate triage if toxicities escalate.
ANC: 2,100 / μL • Safe to proceed with infusion
Ondansetron & Dexamethasone taken 1h prior
Comprehensive oncology cockpit designed specifically for Medical, Surgical, and Radiation Oncologists to track patient cohorts and streamline tumor board reviews.
Launch the live interactive environments directly in your browser. Experience the Oncologist Hospital EMR Cockpit or the Patient Chemotherapy Companion with sample clinical data.
OncoCare is an integrated AI-powered oncology platform that unifies patient care management, chemotherapy tracking, and clinician decision support. From initial biopsy diagnosis and molecular genomics to chemotherapy adherence and survivorship, OncoCare connects cancer patients and oncology specialists in an intuitive, secure ecosystem.
Structured daily schedule with automated pre-medication alerts, hydration prompts, and oral oncolytic adherence trackers.
Explore Patient Diary →Collaborative multi-specialty case reviews with 1-click WhatsApp invites for surgical, radiation, pathology, and radiology oncologists to review mCODE records and cast consensus votes.
Explore Tumor Board →Instant ABHA ID creation, consent manager verification, and seamless electronic medical record sharing via national health networks.
View Compliance →Interactive CTCAE-based assessment that alerts oncologists immediately when adverse events cross clinical severity thresholds.
Read Triage Mechanism →Standardized ASCO/NCCN regimens with Mosteller BSA & Calvert AUC calculators. Dispatches instant pre-loaded companion access to patients via WhatsApp & SMS with zero sign-up friction.
View Protocol Builder →Enterprise-grade 256-bit encryption at rest and in transit with strict role-based access control (RBAC) and audit logging in MeitY-empanelled Indian data centers.
Check Security Standards →The OncoCare Patient App is an automated cancer care companion that guides patients through every cycle of chemotherapy, immunotherapy, and supportive care. It enables 1-tap CTCAE symptom reporting, automated pre-medication adherence reminders, doorstep lab collections, and 24/7 hospital oncology triage escalation.
The OncoCare Clinician EMR is an intelligent oncology EHR designed for medical, surgical, and radiation oncologists. It automates BSA and AUC chemotherapy dosing, evaluates real-time adverse toxicity events using CTCAE criteria, and coordinates multidisciplinary virtual tumor boards with structured mCODE documentation.
"Standardized oncology clinical data capture, patient-reported outcome measures (PROMs), and coordinated multidisciplinary tumor boards form the essential foundation of high-quality, evidence-based cancer care."
OncoCare Evidence-Based Care Pathways are specialized clinical protocol engines covering Medical, Surgical, Radiation, and Genomic Oncology. Dedicated clinical workflows and protocol engines covering over 120 verified regimens compliant with NCCN, ASCO, and ICMR standards across Indian cancer hospitals.
"A comprehensive response to cancer requires integrated care systems spanning early detection, protocol-guided treatment adherence, and proactive supportive monitoring to significantly improve survival and quality of life."
Protocol-driven chemotherapy ordering, automated Mosteller BSA and Calvert carboplatin AUC dosing, systemic immunotherapy protocols, and NCCN/ICMR-compliant pre-chemo hematologic gating checklists.
Somatic and germline Next-Generation Sequencing (NGS) ingestion (EGFR, ALK, KRAS, BRAF, BRCA1/2, HER2). Molecular tumor board dossier generation and actionable targeted therapy matching.
Comprehensive TNM 8th Edition clinical and pathological cancer staging, structured synoptic operative reports, surgical margin documentation, and seamless coordination with adjuvant medical oncology.
Multidisciplinary coordination for concurrent chemoradiation therapy (CCRT). Organ-at-risk (OAR) dose tracking, radiation toxicity surveillance, and DICOM-enabled RT contour reviews in Tumor Boards.
Standardized clinical pathways for acute and chronic leukemias (AML/ALL/CML), lymphomas (Hodgkin & Non-Hodgkin DLBCL), and multiple myeloma with strict absolute neutrophil count (ANC) tracking.
Automated CTCAE v5.0 acute toxicity triage, febrile neutropenia emergency escalation, hospital daycare chemo chair scheduling, and supervised home oncology nursing across Mumbai, Delhi, and Bengaluru.
OncoCare’s ABDM Architecture is a certified digital health gateway connecting cancer centers to India's national Ayushman Bharat health network. Built in alignment with the Ayushman Bharat Digital Mission (ABDM), it supports HL7 FHIR v4.0 standards, instant ABHA creation, and consent-managed health data exchange.
Instant ABHA creation and KYC linking using Aadhaar OTP / Mobile verification.
Granular electronic consent artifacts enabling patients to approve record sharing.
Standardized diagnostic reports, prescription bundles, and discharge summaries.
Encrypted data vaults hosted in MeitY-empanelled Tier-IV data centers in Mumbai with strict multi-tenant isolation and audit trails.
The ICMR 2023 Ethical AI Guardrails in OncoCare are 10 mandatory clinical principles enforcing human-in-the-loop oncologist oversight for all AI algorithms. Designed following the Indian Council of Medical Research (ICMR) Ethical Guidelines for Application of Artificial Intelligence in Biomedical Research and Healthcare (2023), every algorithmic tool operates under verifiable human-in-the-loop clinical supervision with zero black-box autonomy.
"Artificial intelligence in clinical healthcare must strictly ensure human autonomy, patient safety, algorithmic explainability, and data confidentiality, operating with mandatory clinician-in-the-loop oversight at every therapeutic stage."
Patients retain sovereignty over clinical care. Full informed consent is obtained prior to algorithmic assessment, with an instant, one-click opt-out to human oncologists at every step.
Pre-defined clinical safety cutoffs prevent harm. Automated emergency triage flags high-risk oncologic toxicities (febrile neutropenia, acute dyspnea, hemorrhage) for urgent human care.
No black-box decision making. Every AI recommendation surfaces clinical rationale, biomarker evidence levels (NCCN / ESMO / ICMR), and confidence scores for treating oncologists.
Zero-knowledge health data governance compliant with India's Digital Personal Data Protection (DPDP) Act 2023 and ABDM M1-M3 consent manager architecture.
Clear legal and operational demarcation. The AI is an assistive decision-support tool; the primary treating oncologist retains sole prescribing authority and clinical accountability.
Trained and calibrated on representative oncology datasets reflecting Indian patient demographics, genetic profiles, epidemiological variations, and nutritional factors.
Cancer care without linguistic or geographic barriers. Universal UI engineered for low-bandwidth 4G connectivity, offline caching, and multilingual voice/text support across 22+ Indian languages.
Proactive mitigation of algorithmic bias. Treatment guidance, toxicity alerting, and home-care schedules are blind to socioeconomic background, gender, or geographic tier.
Evidence-based validation against standard oncology guidelines (NCCN, ESMO, ICMR consensus guidelines) with continuous retrospective outcome tracking.
Ongoing oversight by Institutional Ethics Committees (IEC), data safety monitoring boards, continuous drift detection, and post-deployment pharmacovigilance logging.
Clear answers for patients, oncologists, hospital CIOs, and administrators.
Oncology is the branch of medicine dedicated to the study, diagnosis, staging, and treatment of cancer. The oncology meaning derives from the Greek “onkos” (tumor or mass) and “logos” (study). The medical definition of oncology covers benign and malignant neoplasms, systemic onco medicine (chemotherapy and immunotherapy), surgical oncology, and radiation oncology. For an in-depth clinical overview, read our Complete Guide to What is Oncology.
Oncology is the study of cancer and cellular neoplastic mutations. It explores how normal cells mutate to form solid tumors (breast, lung, gastrointestinal, prostate) or liquid hematological cancers (leukemias and lymphomas), and evaluates clinical evidence published in leading oncology journals to administer targeted, curative treatments.
Yes, you can track chemotherapy side effects at home using OncoCare's intelligent CTCAE v5.0 symptom diary. When patients log daily body temperature, nausea, mucositis, or fatigue on the Patient App, the system automatically grades toxicities in real time and alerts the hospital oncology team if red flags emerge (such as chemotherapy fever over 100.4°F).
OncoCare links patients and clinicians through a dual-synchronized digital health architecture. As soon as a patient logs vitals or side effects in the mobile app, the data is algorithmically triaged and reflected immediately in the oncologist’s EMR dashboard for coordinated action.
Yes, OncoCare integrates directly with existing hospital HIS/EMR systems via bidirectional HL7 FHIR APIs and webhooks. It connects seamlessly with Epic, Cerner, and proprietary hospital software for instant patient demographic synchronization, lab result ingestion, and billing workflows.
ABHA and ABDM compliance allows cancer patients to create a unified longitudinal health locker across all oncology providers. Patients can securely link and share biopsy reports, genomic profiles, and chemotherapy summaries with treating specialists across India with one-click consent.
Yes, OncoCare is fully compliant with India's Digital Personal Data Protection (DPDP) Act 2023 and ABDM standards. All patient health records are protected with 256-bit AES encryption at rest, TLS 1.3 in transit, and hosted in MeitY-empanelled Tier-IV data centers in Mumbai.
Predictable, ethical pricing for cancer care teams and healthcare institutions. Transactions are secured and processed in full compliance with RBI guidelines and PCI-DSS Level 1 security standards.
Personalized chemo adherence, daily PROMs & symptom diary.
Longitudinal cockpit for medical, surgical & radiation oncologists.
Multi-specialty oncologist consensus for complex cases.